1. Longitudinal analysis of quality of life in patients treated for differentiated thyroid cancer. Issue 6 (December 2019) Authors: van Velsen, Evert F S; Massolt, Elske T; Heersema, Hélène; Kam, Boen L R; van Ginhoven, Tessa M; Visser, W Edward; Peeters, Robin P Journal: European journal of endocrinology Issue: Volume 181:Issue 6(2019) Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0, Tyr3]octreotate. Issue 5 (May 2017) Authors: Brabander, Tessa; van der Zwan, Wouter A; Teunissen, Jaap J M; Kam, Boen L R; de Herder, Wouter W; Feelders, Richard A; Krenning, Eric P; Kwekkeboom, Dik J Journal: Endocrine-related cancer Issue: Volume 24:Issue 5(2017) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE. Issue 1 (July 2019) Authors: Zandee, Wouter T; Feelders, Richard A; Smit Duijzentkunst, Daan A; Hofland, Johannes; Metselaar, R Mick; Oldenburg, Rogier A; van Linge, Anne; Kam, Boen L R; Teunissen, Jaap J M; Korpershoek, Esther; Hendriks, Johanna M; Abusaris, Huda; Slagter, Cleo; Franssen, Gaston J H; Brabander, Tessa; De He... Journal: European journal of endocrinology Issue: Volume 181:Issue 1(2019) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗